ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
ANI Pharmaceuticals (NASDAQ:ANIP) announced its participation in the upcoming Leerink Partners Therapeutics Forum, focusing on I&I and Metabolism. The company's President and CEO, Nikhil Lalwani, will be conducting one-on-one meetings with investors during the event, which takes place on July 8, 2025, in Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) ha annunciato la sua partecipazione al prossimo Leerink Partners Therapeutics Forum, incentrato su I&I e Metabolismo. Il Presidente e CEO dell'azienda, Nikhil Lalwani, terr脿 incontri individuali con gli investitori durante l'evento, che si svolger脿 il 8 luglio 2025 a Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) anunci贸 su participaci贸n en el pr贸ximo Leerink Partners Therapeutics Forum, enfocado en I&I y Metabolismo. El Presidente y CEO de la compa帽铆a, Nikhil Lalwani, realizar谩 reuniones individuales con inversores durante el evento, que tendr谩 lugar el 8 de julio de 2025 en Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP)電� I&I 氚� 雽�靷棎 欷戩爯鞚� 霊� 雼り岸撵槫電� Leerink Partners Therapeutics Forum鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 靷灔 瓴� CEO鞚� Nikhil Lalwani臧赌 2025雲� 7鞗� 8鞚� 氤挫姢韯�, MA鞐愳劀 鞐措Μ電� 頄夓偓 旮瓣皠 霃欖晥 韴瀽鞛愲摛瓿� 鞚茧寑鞚� 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
ANI Pharmaceuticals (NASDAQ:ANIP) a annonc茅 sa participation au prochain Leerink Partners Therapeutics Forum, ax茅 sur l'I&I et le m茅tabolisme. Le pr茅sident et CEO de la soci茅t茅, Nikhil Lalwani, tiendra des r茅unions individuelles avec des investisseurs lors de l'茅v茅nement qui se d茅roulera le 8 juillet 2025 脿 Boston, MA.
ANI Pharmaceuticals (NASDAQ:ANIP) gab seine Teilnahme am bevorstehenden Leerink Partners Therapeutics Forum bekannt, das sich auf I&I und Stoffwechsel konzentriert. Der Pr盲sident und CEO des Unternehmens, Nikhil Lalwani, wird w盲hrend der Veranstaltung am 8. Juli 2025 in Boston, MA, Einzelgespr盲che mit Investoren f眉hren.
- None.
- None.
PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (鈥淎NI鈥� or the 鈥淐ompany鈥�) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host 1x1 meetings at the Leerink Partners Therapeutics Forum: I&I and Metabolism on Tuesday, July 8, 2025, in Boston, MA.
About ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of 鈥淪erving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit聽.
Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E:
Source: ANI Pharmaceuticals, Inc.
FAQ
When is ANI Pharmaceuticals (ANIP) participating in the Leerink Partners Therapeutics Forum?
Who will represent ANI Pharmaceuticals at the Leerink Partners Forum?
What type of meetings will ANI Pharmaceuticals conduct at the Leerink Partners Forum?
What is the focus of the Leerink Partners Therapeutics Forum where ANIP will participate?
